Pranaxt
Prana develops a xenotransplantation platform to address the severe organ shortage by creating a reliable supply of organs. The company utilizes gene editing and cloning technologies to engineer porcine organs that are compatible for human transplantation. This biotechnology aims to make life-saving organ transplants accessible and scalable for patients in need.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Prana develops a xenotransplantation platform to address the severe organ shortage by creating a reliable supply of organs. The company utilizes gene editing and cloning technologies to engineer porcine organs that are compatible for human transplantation. This biotechnology aims to make necessary organ transplants accessible and scalable for patients facing end-stage organ failure.